These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23292662)

  • 1. Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea.
    Geerdes-Fenge HF; Löbermann M; Nürnberg M; Fritzsche C; Koball S; Henschel J; Höhn R; Schober HC; Mitzner S; Podbielski A; Reisinger EC
    Infection; 2013 Jun; 41(3):669-73. PubMed ID: 23292662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4.
    Loos S; Aulbert W; Hoppe B; Ahlenstiel-Grunow T; Kranz B; Wahl C; Staude H; Humberg A; Benz K; Krause M; Pohl M; Liebau MC; Schild R; Lemke J; Beringer O; Müller D; Härtel C; Wigger M; Vester U; Konrad M; Haffner D; Pape L; Oh J; Kemper MJ
    Clin Infect Dis; 2017 Jun; 64(12):1637-1643. PubMed ID: 28329394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011.
    Werber D; King LA; Müller L; Follin P; Buchholz U; Bernard H; Rosner B; Ethelberg S; de Valk H; Höhle M
    Am J Epidemiol; 2013 Sep; 178(6):984-92. PubMed ID: 23935124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.
    Frank C; Werber D; Cramer JP; Askar M; Faber M; an der Heiden M; Bernard H; Fruth A; Prager R; Spode A; Wadl M; Zoufaly A; Jordan S; Kemper MJ; Follin P; Müller L; King LA; Rosner B; Buchholz U; Stark K; Krause G;
    N Engl J Med; 2011 Nov; 365(19):1771-80. PubMed ID: 21696328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2011 German Enterohemorrhagic Escherichia Coli O104:H4 Outbreak-The Danger Is Still Out There.
    Kampmeier S; Berger M; Mellmann A; Karch H; Berger P
    Curr Top Microbiol Immunol; 2018; 416():117-148. PubMed ID: 30062592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.
    Delmas Y; Vendrely B; Clouzeau B; Bachir H; Bui HN; Lacraz A; Hélou S; Bordes C; Reffet A; Llanas B; Skopinski S; Rolland P; Gruson D; Combe C
    Nephrol Dial Transplant; 2014 Mar; 29(3):565-72. PubMed ID: 24293658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study.
    Vonberg RP; Höhle M; Aepfelbacher M; Bange FC; Belmar Campos C; Claussen K; Christner M; Cramer JP; Haller H; Hornef M; Fickenscher H; Fraedrich K; Knobloch JK; Kühbacher T; Manns MP; Nitschke M; Peters G; Pulz M; Rohde H; Roseland RT; Sayk F; Schaumburg F; Schöcklmann HO; Schubert S; Solbach W; Karch H; Suerbaum S
    Clin Infect Dis; 2013 Apr; 56(8):1132-40. PubMed ID: 23300241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Shiga toxin 2 antibodies in enterohemorrhagic Escherichia coli O104:H4 infected patients may predict hemolytic uremic syndrome.
    Dammermann W; Mihajlov V; Middendorf B; Mellmann A; Karch H; Lüth S; Ullrich S
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1353-1356. PubMed ID: 29280264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.
    Nitschke M; Sayk F; Härtel C; Roseland RT; Hauswaldt S; Steinhoff J; Fellermann K; Derad I; Wellhöner P; Büning J; Tiemer B; Katalinic A; Rupp J; Lehnert H; Solbach W; Knobloch JK
    JAMA; 2012 Mar; 307(10):1046-52. PubMed ID: 22416100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outbreak of Shiga toxin-producing Escherichia coli O104:H4 associated with organic fenugreek sprouts, France, June 2011.
    King LA; Nogareda F; Weill FX; Mariani-Kurkdjian P; Loukiadis E; Gault G; Jourdan-DaSilva N; Bingen E; Macé M; Thevenot D; Ong N; Castor C; Noël H; Van Cauteren D; Charron M; Vaillant V; Aldabe B; Goulet V; Delmas G; Couturier E; Le Strat Y; Combe C; Delmas Y; Terrier F; Vendrely B; Rolland P; de Valk H
    Clin Infect Dis; 2012 Jun; 54(11):1588-94. PubMed ID: 22460976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology.
    Mellmann A; Harmsen D; Cummings CA; Zentz EB; Leopold SR; Rico A; Prior K; Szczepanowski R; Ji Y; Zhang W; McLaughlin SF; Henkhaus JK; Leopold B; Bielaszewska M; Prager R; Brzoska PM; Moore RL; Guenther S; Rothberg JM; Karch H
    PLoS One; 2011; 6(7):e22751. PubMed ID: 21799941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological and Ecological Characterization of the EHEC O104:H4 Outbreak in Hamburg, Germany, 2011.
    Tahden M; Manitz J; Baumgardt K; Fell G; Kneib T; Hegasy G
    PLoS One; 2016; 11(10):e0164508. PubMed ID: 27723830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.
    Menne J; Nitschke M; Stingele R; Abu-Tair M; Beneke J; Bramstedt J; Bremer JP; Brunkhorst R; Busch V; Dengler R; Deuschl G; Fellermann K; Fickenscher H; Gerigk C; Goettsche A; Greeve J; Hafer C; Hagenmüller F; Haller H; Herget-Rosenthal S; Hertenstein B; Hofmann C; Lang M; Kielstein JT; Klostermeier UC; Knobloch J; Kuehbacher M; Kunzendorf U; Lehnert H; Manns MP; Menne TF; Meyer TN; Michael C; Münte T; Neumann-Grutzeck C; Nuernberger J; Pavenstaedt H; Ramazan L; Renders L; Repenthin J; Ries W; Rohr A; Rump LC; Samuelsson O; Sayk F; Schmidt BM; Schnatter S; Schöcklmann H; Schreiber S; von Seydewitz CU; Steinhoff J; Stracke S; Suerbaum S; van de Loo A; Vischedyk M; Weissenborn K; Wellhöner P; Wiesner M; Zeissig S; Büning J; Schiffer M; Kuehbacher T;
    BMJ; 2012 Jul; 345():e4565. PubMed ID: 22815429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli O104:H4 in adults.
    Derad I; Obermann B; Katalinic A; Eisemann N; Knobloch JK; Sayk F; Wellhöner P; Lehnert H; Solbach W; Süfke S; Steinhoff J; Nitschke M
    Nephrol Dial Transplant; 2016 Jan; 31(1):95-103. PubMed ID: 26180049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections.
    Bell BP; Griffin PM; Lozano P; Christie DL; Kobayashi JM; Tarr PI
    Pediatrics; 1997 Jul; 100(1):E12. PubMed ID: 9200386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Household transmission of haemolytic uraemic syndrome associated with Escherichia coli O104:H4, south-western France, June 2011.
    Aldabe B; Delmas Y; Gault G; Vendrely B; Llanas B; Charron M; Castor C; Ong N; Weill F; Mariani-Kurkdjian P; Terrier F; Desjardin M; Simoes J; Le Bihan B; Combe C; Rolland P
    Euro Surveill; 2011 Aug; 16(31):. PubMed ID: 21871216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of an outbreak of bloody diarrhea complicated with hemolytic uremic syndrome.
    Chokoshvili O; Lomashvili K; Malakmadze N; Geleishvil M; Brant J; Imnadze P; Chitadze N; Tevzadze L; Chanturia G; Tevdoradze T; Tsertsvadze T; Talkington D; Mody RK; Strockbine N; Gerber RA; Maes E; Rush T
    J Epidemiol Glob Health; 2014 Dec; 4(4):249-59. PubMed ID: 25455642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak.
    Corogeanu D; Willmes R; Wolke M; Plum G; Utermöhlen O; Krönke M
    BMC Microbiol; 2012 Aug; 12():160. PubMed ID: 22853739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition.
    Tarr GAM; Oltean HN; Phipps AI; Rabinowitz P; Tarr PI
    Int J Med Microbiol; 2018 Oct; 308(7):921-926. PubMed ID: 30257808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.